Follow
Manuel Battegay
Manuel Battegay
University of Basel, Switzerland
Verified email at usb.ch
Title
Cited by
Cited by
Year
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ...
Gastroenterology 138 (4), 1338-1345. e7, 2010
14622010
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
G Greub, B Ledergerber, M Battegay, P Grob, L Perrin, H Furrer, ...
The Lancet 356 (9244), 1800-1805, 2000
12452000
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
B Ledergerber, M Egger, M Opravil, A Telenti, B Hirschel, M Battegay, ...
The Lancet 353 (9156), 863-868, 1999
11181999
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
10332019
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
M Egger, B Hirschel, P Francioli, P Sudre, M Wirz, M Flepp, M Rickenbach, ...
Bmj 315 (7117), 1194-1199, 1997
7731997
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
B Hasse, B Ledergerber, H Furrer, M Battegay, B Hirschel, M Cavassini, ...
Clinical infectious diseases 53 (11), 1130-1139, 2011
7512011
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study
B Ledergerber, M Egger, V Erard, R Weber, B Hirschel, H Furrer, ...
Jama 282 (23), 2220-2226, 1999
6281999
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation
S Marcel, AL Christian, N Richard, S Silvia, H Emma, F Jacques, Z Marcel, ...
Swiss medical weekly 150, w202205, 2020
5992020
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5772008
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
GR Kaufmann, L Perrin, G Pantaleo, M Opravil, H Furrer, A Telenti, ...
Archives of internal medicine 163 (18), 2187-2195, 2003
5622003
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-or 96-well plates
M Battegay, S Cooper, A Althage, J Bänziger, H Hengartner, ...
Journal of virological methods 33 (1-2), 191-198, 1991
5221991
Decreasing mortality and changing patterns of causes of death in the S wiss HIV C ohort S tudy
R Weber, M Ruppik, M Rickenbach, A Spörri, H Furrer, M Battegay, ...
HIV medicine 14 (4), 195-207, 2013
4902013
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
J Fellay, B Ledergerber, E Bernasconi, H Furrer, M Battegay, B Hirschel, ...
The Lancet 358 (9290), 1322-1327, 2001
4842001
Immune reconstitution in HIV-infected patients
KH Mayer, HH Hirsch, G Kaufmann, P Sendi, M Battegay
Clinical Infectious Diseases 38 (8), 1159-1166, 2004
4612004
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
4422010
Characteristics, Determinants, and clinical relevance of CD4 T cell recovery to< 500 cells/µL in HIV type 1—infected individuals receiving potent antiretroviral therapy
GR Kaufmann, H Furrer, B Ledergerber, L Perrin, M Opravil, P Vernazza, ...
Clinical infectious diseases 41 (3), 361-372, 2005
4342005
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials
HC Bucher, LE Griffith, GH Guyatt, P Sudre, M Naef, P Sendi, M Battegay
Aids 13 (4), 501-507, 1999
4321999
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice
M Battegay, D Moskophidis, A Rahemtulla, H Hengartner, TW Mak, ...
Journal of virology 68 (7), 4700-4704, 1994
4071994
Discontinuation of Primary Prophylaxis against Pneumocystis carinii Pneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy
H Furrer, M Egger, M Opravil, E Bernasconi, B Hirschel, M Battegay, ...
New England Journal of Medicine 340 (17), 1301-1306, 1999
3571999
Fibroblasts as efficient antigen-presenting cells in lymphoid organs
TM Kündig, MF Bachmann, C DiPaolo, JJL Simard, M Battegay, H Lother, ...
Science 268 (5215), 1343-1347, 1995
3521995
The system can't perform the operation now. Try again later.
Articles 1–20